Lemaitre Vascular Inc

Lemaitre Vascular Inc

LMAT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.85B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lemaitre Vascular IncLemaitre Vascular Inc27.91.17%16%80.5
$95.00

Target Price by Analysts

8.1% upsideLemaitre Vascular Target Price DetailsTarget Price
$115.04

Current Fair Value

30.8% upside

Undervalued by 30.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.85 Billion
Enterprise Value$2.01 Billion
Annual dividend$0.95
Dividend yield1.17%
Earnings per Share$2.55
Beta0.47
Outstanding Shares22,858,000

Return

Return on Equity15.62%ROE
Return on Assets10.25%
Return on Invested Capital12.61%

Valuation & Multiples

P/E Ratio27.91P/E Ratio
PEG117.57PEG
Price to Sales7.99Price to Sales
Price to Book Ratio4.88Price to Book Ratio
Enterprise Value to Revenue7.68
Enterprise Value to EBIT26.17
Enterprise Value to Net Income30
Total Debt to Enterprise0.09
Debt to Equity0.45Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS Estimate
$0.69
Consensus analyst estimate
Revenue Estimate
$67.39 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 24, 2027
EPS Estimate
$0.78
Consensus analyst estimate
Revenue Estimate
$72.11 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 122.22%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %12.63%▼ 88.28%
Total Invested$238.37M▼ 89.23%
Investors Holding74▼ 255.00%

About Lemaitre Vascular Inc

CEO: George LeMaitre

Lemaitre Vascular Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in Lemaitre Vascular. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 5 top investors increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 5 open-market insider sales for Lemaitre Vascular in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.